Kelsey Goodwin – Piper Sandler

Piper Sandler

A Piper Sandler analyst with 54 tracked ratings across 25 distinct tickers has a 4.8-star track record and a 90% success rate on the captured sample.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

8 days ago

2026-05-27 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 12
Hold: 2
Bearish: 0

Aggregated

90% success rate

Bullish: 0
Hold: 2
Bearish: 0

Aggregated

Not available

Bullish: 18
Hold: 3
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
LONA	2026-05-27	buy	$20.00	Aggregated
TNGX	2026-05-15	hold	$24.00	Aggregated
ERAS	2026-05-12	buy	$18.00	Aggregated
JANX	2026-05-08	buy	$26.00	Aggregated
RVMD	2026-05-07	buy	$172.00	Aggregated
ORIC	2026-05-05	buy	$22.00	Aggregated
SMMT	2026-05-01	hold	$16.00	Aggregated
OLMA	2026-04-20	buy	$40.00	Aggregated
URGN	2026-04-20	buy	$40.00	Aggregated
CGON	2026-03-26	buy	-	Aggregated
TARA	2026-03-26	buy	-	Aggregated
RLMD	2026-03-24	buy	$12.00	Aggregated
BDTX	2026-03-17	buy	$8.00	Aggregated
ERAS	2026-03-13	buy	$18.00	Aggregated
RVMD	2026-02-26	buy	$120.00	Aggregated
BDTX	2026-01-16	buy	$8.00	Aggregated
CGON	2026-01-16	buy	$70.00	Aggregated
ERAS	2026-01-16	buy	$11.00	Aggregated
ERAS	2026-01-07	buy	$5.00	Aggregated
ORIC	2026-01-07	buy	$22.00	Aggregated
TARA	2026-01-07	buy	$24.00	Aggregated
BCAX	2025-12-08	buy	$36.00	Aggregated
NUVL	2025-11-20	buy	$128.00	Aggregated
BDTX	2025-11-18	buy	$9.00	Aggregated
BDTXBLACK DIAMOND THERAPEUTICS INC	2025-11-18	unknown	$9.00	Aggregated
DAWNDAY ONE BIOPHARMACEUTICALS INC	2025-11-05	unknown	$26.00	Aggregated
NUVL	2025-10-27	buy	$128.00	Aggregated
NUVLNUVALENT INC - ORDINARY SHARES - CLASS A	2025-10-27	unknown	$128.00	Aggregated
BCAX	2025-08-19	buy	$36.00	Aggregated
BCAXBICARA THERAPEUTICS INC. COMMON STOCK	2025-08-19	unknown	$36.00	Aggregated
CGON	2025-08-19	buy	$55.00	Aggregated
CGONCG ONCOLOGY INC.	2025-08-19	unknown	$55.00	Aggregated
JANXJANUX THERAPEUTICS INC	2025-08-19	unknown	$42.00	Aggregated
NUVL	2025-08-19	buy	$112.00	Aggregated
RVMDREVOLUTION MEDICINES INC	2025-08-19	unknown	$75.00	Aggregated
SMMT	2025-08-19	hold	$21.00	Aggregated
SMMTSUMMIT THERAPEUTICS INC	2025-08-19	hold	$21.00	Aggregated
TNGXTANGO THERAPEUTICS INC	2025-08-19	unknown	$11.00	Aggregated
URGN	2025-08-19	buy	$36.00	Aggregated
URGNUROGEN PHARMA LTD	2025-08-19	unknown	$36.00	Aggregated

Tickers covered(25)

Ticker	Ratings	Last rating	Sources
LONA	1	2026-05-27	Aggregated
TNGX	2	2026-05-15	Aggregated
ERAS	4	2026-05-12	Aggregated
JANX	2	2026-05-08	Aggregated
RVMD	3	2026-05-07	Aggregated
ORIC	2	2026-05-05	Aggregated
SMMT	3	2026-05-01	Aggregated
OLMA	2	2026-04-20	Aggregated
URGN	2	2026-04-20	Aggregated
CGON	3	2026-03-26	Aggregated
TARA	2	2026-03-26	Aggregated
RLMD	1	2026-03-24	Aggregated
BDTX	3	2026-03-17	Aggregated
BCAX	2	2025-12-08	Aggregated
NUVL	3	2025-11-20	Aggregated
BDTXBLACK DIAMOND THERAPEUTICS INC	1	2025-11-18	Aggregated
DAWNDAY ONE BIOPHARMACEUTICALS INC	2	2025-11-05	Aggregated
NUVLNUVALENT INC - ORDINARY SHARES - CLASS A	2	2025-10-27	Aggregated
BCAXBICARA THERAPEUTICS INC. COMMON STOCK	2	2025-08-19	Aggregated
CGONCG ONCOLOGY INC.	2	2025-08-19	Aggregated
JANXJANUX THERAPEUTICS INC	2	2025-08-19	Aggregated
RVMDREVOLUTION MEDICINES INC	2	2025-08-19	Aggregated
SMMTSUMMIT THERAPEUTICS INC	2	2025-08-19	Aggregated
TNGXTANGO THERAPEUTICS INC	2	2025-08-19	Aggregated
URGNUROGEN PHARMA LTD	2	2025-08-19	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.